{"id":4396,"date":"2026-11-18T09:00:00","date_gmt":"2026-11-18T13:00:00","guid":{"rendered":"https:\/\/www.insilens.com\/?p=4396"},"modified":"2026-11-18T21:45:36","modified_gmt":"2026-11-19T01:45:36","slug":"ferroptotic-tumors-use-pge2-to-blunt-immune-clearance","status":"publish","type":"post","link":"https:\/\/www.insilens.com\/?p=4396","title":{"rendered":"Ferroptotic Tumors Use PGE2 to Blunt Immune Clearance"},"content":{"rendered":"<p><img fetchpriority=\"high\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/11\/20261118_Ramsauer_Ferroptosis_Technology_and_Modalities-768x432.png\" alt=\"\" class=\"attachment-medium_large size-medium_large wp-image-4407\" srcset=\"https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/11\/20261118_Ramsauer_Ferroptosis_Technology_and_Modalities-768x432.png 768w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/11\/20261118_Ramsauer_Ferroptosis_Technology_and_Modalities-300x169.png 300w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/11\/20261118_Ramsauer_Ferroptosis_Technology_and_Modalities-1024x576.png 1024w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/11\/20261118_Ramsauer_Ferroptosis_Technology_and_Modalities-1536x864.png 1536w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/11\/20261118_Ramsauer_Ferroptosis_Technology_and_Modalities.png 1672w\" sizes=\"(max-width: 768px) 100vw, 768px\" \/><\/p>\n<p><strong>Company<\/strong><\/p>\n<p>Academic (Ramsauer et al., Nature)<\/p>\n<p><strong>Event Type<\/strong><\/p>\n<p>Peer-reviewed publication<\/p>\n<p><strong>Modality<\/strong><\/p>\n<p>Ferroptosis induction combined with PGE2 pathway blockade (hypothesis)<\/p>\n<p><strong>Asset<\/strong><\/p>\n<p>PGE2\u2013EP2\/EP4 axis<\/p>\n<p><strong>Target<\/strong><\/p>\n<p>PGE2 production; EP2\/EP4 receptors<\/p>\n<p><strong>Disease Area<\/strong><\/p>\n<p>Solid tumors (preclinical models)<\/p>\n<h4>Summary<\/h4>\n<p>A peer-reviewed Nature paper published online November 18 identifies a mechanism by which ferroptotic tumor cells suppress antitumor immunity. Lipid peroxidation and membrane permeabilization permit calcium influx, activating p38 MAPK and prostaglandin E2 production; PGE2 inhibits cDC1-driven CD8 T-cell responses in the tested models.<\/p>\n<p>Ramsauer and colleagues showed that blocking PGE2 production or EP2\/EP4 signaling preserved tumor-cell ferroptosis while restoring immune-mediated tumor clearance in preclinical systems. This is a full peer-reviewed version of record, not a preprint or company readout. The paper does not report a clinical combination trial.<\/p>\n<h4>Deep Analysis<\/h4>\n<p><strong>Interpretation A:<\/strong> pairing ferroptosis induction with suppression of the PGE2\u2013EP2\/EP4 axis may rescue immune priming and create a rational combination strategy.<\/p>\n<p><strong>Interpretation B:<\/strong> PGE2 is one of several suppressive outputs, and model-dependent rescue may not translate in heterogeneous human tumors where ferroptosis exposure, stromal sources and immune context vary. COX or p38 inhibition can alter immunity and tumor biology beyond the proposed pathway; dose scheduling and tissue access are unresolved. Biomarkers should establish tumor ferroptosis, intratumoral PGE2, functional cDC1 and CD8 activation, not merely tumor shrinkage. Competitive displacement of existing immunotherapy would require clinical benefit with tolerable systemic exposure.<\/p>\n<h4>Company and Product Background<\/h4>\n<p>Ferroptosis is iron-associated lipid-peroxide cell death, a proposed vulnerability in resistant cancers. PGE2 is an immunomodulatory lipid. cDC1 cells cross-present tumor antigens and help prime CD8 T-cell responses; EP2\/EP4 are PGE2 receptors.<\/p>\n<h4>Signal Extraction<\/h4>\n<ul>\n<li>Primary paper supports causal pathway in experimental models.<\/li>\n<li>Missing: patient tumor pharmacodynamics, human dose separation, immunotoxicity, PK, suitable combinations and IP position.<\/li>\n<li>Upgrade: human tumor explant and prospective biomarker-linked clinical response.<\/li>\n<li>Downgrade: rescue restricted to one model or counterproductive systemic COX\/EP blockade.<\/li>\n<li>Falsifier: no immune improvement despite verified dual pathway engagement.<\/li>\n<\/ul>\n<h4>InSilens Take<\/h4>\n<p>The work refines a therapeutic design hypothesis for ferroptosis-inducing drugs; no treatment-ready combination has been established.<\/p>\n<h4>Signal Assessment<\/h4>\n<p>Signal Importance: 4 of 5. Signal Direction: mixed. Confidence in Facts: High. Confidence in Interpretation: Moderate.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A peer-reviewed Nature paper published online November 18 identifies a mechanism by which ferroptotic tumor cells suppress antitumor immunity. Lipid peroxidation and membrane permeabilization permit calcium influx, activating p38 MAPK and prostaglandin E2 production;&#8230;<\/p>\n","protected":false},"author":1,"featured_media":4407,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[1539,1243,1538],"class_list":["post-4396","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology-modalities","tag-cancer-immunotherapy","tag-ferroptosis","tag-prostaglandin-e2"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/4396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4396"}],"version-history":[{"count":1,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/4396\/revisions"}],"predecessor-version":[{"id":4422,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/4396\/revisions\/4422"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/media\/4407"}],"wp:attachment":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4396"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4396"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}